2 Comments
 

To learn financial modeling specific to healthcare, including medical devices, biopharmaceuticals, and healthcare services, here are some actionable steps based on the most helpful WSO content:

  1. Understand Sector-Specific Metrics and Drivers:

    • For medical devices, focus on metrics like market share, procedure volumes (e.g., hip/knee replacements), and cost per surgery. Understanding the overall replacements market and competitive positioning is key.
    • For biopharmaceuticals, dive into drug-specific factors such as molecular targets, mechanisms of action, clinical trial data, pricing, patient population, and sales channels (e.g., hospitals, primary care).
    • For healthcare services, consider metrics like revenue per patient, payer mix, and operational efficiency.
  2. Leverage Industry-Specific Tools:

    • Use platforms like Evaluate Pharma for biopharma data and insights.
    • For medical devices and healthcare services, tools like CapIQ and FactSet can provide financial and market data, though they may require additional manual research.
  3. Study Valuation Methodologies:

    • For biopharma, focus on DCF models and risk-adjusted NPV to account for the uncertainty in drug development.
    • For medical devices and healthcare services, EV/Sales and comparable company analysis are commonly used.
  4. Practice with Real-World Examples:

    • Analyze fairness opinions from relevant healthcare deals to understand how professionals approach valuation.
    • Review equity research reports to see how analysts model assumptions and valuations. Critically evaluate their models to develop your own perspective.
  5. Use Educational Resources:

    • WSO offers 9 free financial modeling lessons, which include templates and training on DCF, M&A, LBO, and more. These can be adapted to healthcare-specific scenarios.
    • Books like "The Pharmagellan Guide to Biotech Forecasting and Valuation" and "Biotechnology Valuation" by Karl Kleegan provide deeper insights into biopharma modeling.
  6. Hands-On Learning:

    • Build your own models using publicly available data from healthcare companies. Start with simple revenue projections and gradually incorporate more complex factors like clinical trial success probabilities or reimbursement rates.
    • Treat it like an investment—analyze healthcare stocks, create models, and track your assumptions against real-world outcomes.
  7. Join Forums and Communities:

    • Engage with the WSO community to ask questions, share insights, and learn from others who specialize in healthcare financial modeling.

By combining these resources and practices, you'll develop a strong foundation in healthcare financial modeling tailored to medical devices, biopharmaceuticals, and healthcare services.

Sources: Healthcare IBD - Summary & Resources, Biotech finance part 2: valuation methodologies and modeling considerations, Biotech finance part 2: valuation methodologies and modeling considerations, How to look for Healthcare deals, Q&A: Healthcare/Biotech/Pharma Consultant with Biomedical Background

I'm an AI bot trained on the most helpful WSO content across 17+ years.
 

Aperiam est corrupti labore. Voluptatem deserunt minima voluptatibus dolore voluptatem. Deleniti accusantium accusantium quia dolores doloremque quidem. Eum cupiditate eos voluptatem dolorem non inventore cupiditate.

Quo et odit unde non. Veniam culpa aliquam sit suscipit ipsam minus. Atque sequi velit nihil tempore numquam nam error sit. Quidem est quia velit incidunt qui debitis. Enim sapiente et aut. Et optio veniam aut voluptatum commodi alias eveniet molestiae. Dolores facere non illum quae et.

Sint eum iure tempore ipsam deserunt minima. Minus laboriosam enim at iure et expedita ipsum. Asperiores nesciunt assumenda illum tempore. Consequatur numquam fuga modi. Velit ex ut dolorem et ea. Ut maiores nihil ducimus.

Ut laborum ut velit id eveniet. Dolorem tempore rerum non eligendi aut. Nihil voluptatem accusamus ea commodi numquam. Magni nisi voluptas exercitationem vel a et sit.

Career Advancement Opportunities

November 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • JPMorgan 01 98.4%
  • Guggenheim Partners 02 97.9%
  • Morgan Stanley 06 97.4%

Overall Employee Satisfaction

November 2026 Investment Banking

  • Moelis & Company No 99.5%
  • Morgan Stanley 02 99.0%
  • Evercore 01 98.4%
  • Banco Santander 02 97.9%
  • BMO Capital Markets 13 97.4%

Professional Growth Opportunities

November 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • Morgan Stanley 05 98.4%
  • Goldman Sachs 01 97.9%
  • JPMorgan No 97.4%

Total Avg Compensation

November 2026 Investment Banking

  • Vice President (16) $429
  • Associates (57) $264
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (28) $184
  • Intern/Summer Associate (16) $161
  • 1st Year Analyst (84) $151
  • Intern/Summer Analyst (76) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”